We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-13.89%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$4.5B
AUM Growth
-$744M
Cap. Flow
+$158M
Cap. Flow %
3.51%
Top 10 Hldgs %
18.83%
Holding
605
New
48
Increased
192
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$39.6M
2
HES
Hess
HES
+$34.3M
3
PFE icon
Pfizer
PFE
+$14.5M
4
XYZ
Block Inc
XYZ
+$12.3M
5
KO icon
Coca-Cola
KO
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 29.9%
2 Healthcare 19.98%
3 Consumer Discretionary 10.77%
4 Financials 9.62%
5 Industrials 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKL icon
451
Markel Group
MKL
$23.3B
$386K 0.01%
300
+100
+50% +$137K
GMAB icon
452
Genmab
GMAB
$17.7B
$381K 0.01%
12,000
LGND icon
453
Ligand Pharmaceuticals
LGND
$5.76B
$380K 0.01%
6,893
OCUL icon
454
Ocular Therapeutix
OCUL
$1.79B
$373K 0.01%
95,800
IOVA icon
455
Iovance Biotherapeutics
IOVA
$1.82B
$370K 0.01%
34,000
ALLO icon
456
Allogene Therapeutics
ALLO
$649M
$367K 0.01%
31,400
LYEL icon
457
Lyell Immunopharma
LYEL
$317M
$362K 0.01%
2,700
VEEV icon
458
Veeva Systems
VEEV
$33.1B
$361K 0.01%
1,800
LTHM
459
DELISTED
Livent Corporation
LTHM
$353K 0.01%
+15,500
New +$399K
PSA icon
460
Public Storage
PSA
$60.5B
$353K 0.01%
+1,135
New +$393K
KRYS icon
461
Krystal Biotech
KRYS
$10.1B
$349K 0.01%
5,400
FRPT icon
462
Freshpet
FRPT
$2.93B
$340K 0.01%
6,210
AUTL
463
Autolus Therapeutics
AUTL
$397M
$340K 0.01%
120,000
VCYT icon
464
Veracyte
VCYT
$3.7B
$339K 0.01%
17,000
BBIO icon
465
BridgeBio Pharma
BBIO
$15.7B
$338K 0.01%
38,225
EG icon
466
Everest Group
EG
$14.5B
$334K 0.01%
1,200
-300
-20% -$84.8K
Y
467
DELISTED
Alleghany Corp
Y
$333K 0.01%
+400
New +$335K
RVMD icon
468
Revolution Medicines
RVMD
$39.9B
$332K 0.01%
17,400
PBA icon
469
Pembina Pipeline
PBA
$28.4B
$319K 0.01%
9,000
-3,400
-27% -$131K
RGNX icon
470
Regenxbio
RGNX
$620M
$315K 0.01%
13,000
HCA icon
471
HCA Healthcare
HCA
$87.2B
$315K 0.01%
+1,795
New +$386K
SWTX
472
DELISTED
SpringWorks Therapeutics
SWTX
$314K 0.01%
12,300
BILI icon
473
Bilibili
BILI
$7.99B
$313K 0.01%
12,000
GRFS
474
Grifois
GRFS
$5.36B
$306K 0.01%
27,056
WRB icon
475
W.R. Berkley
WRB
$26.9B
$303K 0.01%
6,750

Similar funds

Erste Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Erste Asset Management held 605 positions worth $4.5B, down 14% from $5.24B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Erste Asset Management deployed $158M of net new capital in Q2 2022, opening 48 new positions and adding to 192 existing holdings. Its largest new stake was East-West Bancorp: 145,208 shares worth $9.42M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $31.4M trimmed.

  • Erste Asset Management's largest Q2 2022 buy was East-West Bancorp: 145,208 shares worth $9.42M.
  • Erste Asset Management added most to Netflix in Q2 2022, an estimated $39.6M increase.
  • Erste Asset Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $31.4M.
  • Erste Asset Management fully exited Houghton Mifflin Harcourt Company in Q2 2022, selling an estimated $19.3M.
  • Erste Asset Management's ten largest holdings make up 19% of its $4.5B portfolio in Q2 2022.
  • Erste Asset Management opened 48 new positions and closed 31 in Q2 2022.
  • Erste Asset Management's portfolio value fell 14% quarter-over-quarter to $4.5B.

Based on Erste Asset Management's 13F filing for Q2 2022, filed 26 Nov 2024.